Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS (2015) Eur Urol 67: 165-170 Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer. Arnold Egloff SA, Du L, Loomans HA, Starchenko A, Su PF, Ketova T, Knoll PB, Wang J, Haddad AQ, Fadare O, Cates JM, Lotan Y, Shyr Y, Clark PE, Zijlstra A (2017) Oncotarget 8: 722-741 Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE (2009) Cancer 115: 770-5 Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG (2005) Cancer 103: 546-52 Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG (2003) Cancer 98: 955-61 Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG (2005) Cancer 104: 36-43 Bladder cancer. Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M, National Comprehensive Cancer Network (NCCN) (2013) J Natl Compr Canc Netw 11: 446-75 Bladder cancer. Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG, National Comprehensive Cancer Network (2009) J Natl Compr Canc Netw 7: 8-39 Bladder cancer. Borden LS, Clark PE, Hall MC (2003) Curr Opin Oncol 15: 227-33 Bladder cancer. Gwynn ES, Clark PE (2006) Curr Opin Oncol 18: 277-83 Bladder cancer. Barocas DA, Clark PE (2008) Curr Opin Oncol 20: 307-14 Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Keegan KA, Resnick MJ, Clark PE (2012) Curr Opin Oncol 24: 278-83 Bladder cancer. Borden LS, Clark PE, Hall MC (2005) Curr Opin Oncol 17: 275-80 Developments and controversies in the management of noninvasive bladder cancer. Bassett JC, Eifler JB, Resnick MJ, Clark PE (2014) Curr Opin Oncol 26: 299-304 Bladder cancer. Morgan TM, Clark PE (2010) Curr Opin Oncol 22: 242-9 Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson CJ, Aghazadeh M, Smith JA, Barocas DA (2011) J Urol 185: 90-6 Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS (2009) J Urol 181: 540-5; discussion 546 Association of procedure volume with radical cystectomy outcomes in a nationwide database. Barbieri CE, Lee B, Cookson MS, Bingham J, Clark PE, Smith JA, Chang SS (2007) J Urol 178: 1418-21; discussion 1421-2 The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. Clark PE, Stein JP, Groshen SG, Miranda G, Cai J, Lieskovsky G, Skinner DG (2004) J Urol 172: 1342-7 Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. Stein JP, Penson DF, Wu SD, Skinner DG (2007) J Urol 178: 756-60 Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, Groshen S, Lieskovsky G, Skinner DG (2007) J Urol 177: 876-81; discussion 881-2 Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. Porter MP, Penson DF (2005) J Urol 173: 1318-22 Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. Stimson CJ, Cookson MS, Barocas DA, Clark PE, Humphrey JE, Patel SG, Smith JA, Chang SS (2010) J Urol 183: 1732-7 Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG (2009) J Urol 181: 2052-8; discussion 2058-9 Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) J Urol 182: 2182-7 Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort. Aghazadeh MA, Barocas DA, Salem S, Clark PE, Cookson MS, Davis R, Gregg J, Stimson CJ, Smith JA, Chang SS (2011) J Urol 185: 85-9 Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. Stimson CJ, Chang SS, Barocas DA, Humphrey JE, Patel SG, Clark PE, Smith JA, Cookson MS (2010) J Urol 184: 1296-300 Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA, Cookson MS (2011) J Urol 186: 829-34 Volume outcomes of cystectomy--is it the surgeon or the setting? Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF (2012) J Urol 188: 2139-44 Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R, Penson DF, Barocas DA, Smith JA, Cookson MS, Chang SS (2013) J Urol 189: 541-7 Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy. Ritch CR, Cookson MS, Chang SS, Clark PE, Resnick MJ, Penson DF, Smith JA, May AT, Anderson CB, You C, Lee H, Barocas DA (2014) J Urol 192: 1360-4 Urinary diversion trends at a high volume, single American tertiary care center. Lowrance WT, Rumohr JA, Clark PE, Chang SS, Smith JA, Cookson MS (2009) J Urol 182: 2369-74 Contemporary open radical cystectomy: analysis of perioperative outcomes. Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA, Cookson MS (2008) J Urol 179: 1313-8; discussion 1318 Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI (2015) Urol Oncol 33: 386.e1-6 The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, Penson DF, Smith JA, Cookson MS (2013) Urol Oncol 31: 871-7 Comprehensive handbook for developing a bladder cancer cystectomy database. Lotan Y, Amiel G, Boorjian SA, Clark PE, Droller M, Gingrich JR, Guzzo TJ, Inman BA, Kamat AM, Karsh L, Nielsen ME, Smith ND, Shariat SF, Svatek RS, Taylor JM, Bladder Cancer Think Tank, Bladder Cancer Advocacy Network (2013) Urol Oncol 31: 812-26 Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device. Thompson IM, Kappa SF, Morgan TM, Barocas DA, Bischoff CJ, Keegan KA, Stratton KL, Clark PE, Resnick MJ, Smith JA, Cookson MS, Chang SS (2014) Urol Oncol 32: 45.e11-5 T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro. Clark PE (2013) Oncology (Williston Park) 27: 872, 921 Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. Patel SG, Cookson MS, Barocas DA, Clark PE, Smith JA, Chang SS (2009) BJU Int 104: 934-7 Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management. Patel SG, Cookson MS, Clark PE, Smith JA, Chang SS (2008) BJU Int 101: 219-22
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.